Arkolith/Insider Trading/ANGN/Form 4

Venkatesan Jay

See Remarks, DirectorAngion Biomedica Corp. (ANGN) · full profile →Form 4 · filed Dec 20, 2021
Net Buying
Open-Market Buys
$106K
Open-Market Sells
$0
Net Open-Market Flow
$106K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2021Buy(P)14K$2.54$35K1.4M
Dec 16, 2021Buy(P)28K$2.55$71K1.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001601485-21-000089) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML